Suchilactone
CAS No. 50816-74-5
Suchilactone( —— )
Catalog No. M31506 CAS No. 50816-74-5
Suchilactone may have the potential to be developed as a treatment of Alzheimer's Disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 486 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSuchilactone
-
NoteResearch use only, not for human use.
-
Brief DescriptionSuchilactone may have the potential to be developed as a treatment of Alzheimer's Disease.
-
DescriptionSuchilactone may have the potential to be developed as a treatment of Alzheimer's Disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number50816-74-5
-
Formula Weight368.4
-
Molecular FormulaC21H20O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Collagen Type II Fra...
Collagen Type II Fragment is an anti-inflammatory peptide that potently inhibits collagen-induced arthritis (CIA) in mice. Collagen Type II Fragment can be used for research on inflammation and immunity.
-
Jacoline
Jacoline, jaconine, jacobine, and jacozine, the hepatotoxic alkaloids, are potentially carcinogenic, mutagenic, and teratogenic and may pose health hazards to the human consumer.
-
Epithalon TFA
Epitalon TFA is an anti-aging agent and telomerase activator.Addition of Epithalon peptide in telomerase-negative human fetal fibroblast culture induced expression of the catalytical subunit, enzymatic activity of telomerase, and telomere elongation, which can be due to reactivation of telomerase gene in somatic cells and indicates the possibility of prolonging life span of a cell population and of the whole organism.
Cart
sales@molnova.com